Implantable Systems and Microparticle Depots: Meeting the Formulation and Manufacturing Challenges of Long-Acting Drug Delivery

Register free: http://www.pharmtech.com/pt_w/implants_depots

Event Overview:
A growing number of APIs suffer from poor water solubility, low bioavailability, and insufficient stability. As more BCS class II IV compounds enter the drug development pipeline, formulatoOriginal Article